Monpoux, F., Dageville, C., Maillotte, S., Immunoglobulines polyvalentes intraveineuses et ictère néonatal par allo-immunisation érythrocytaire (2009) Arch Pediatr, 16, pp. 1289-1294
Gottstein, R., Cooke, R.W., Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn (2003) Arch Dis Child Fetal Neonatal Ed, 88, pp. F6-10
Canadian paediatric society fetus newborn, committee., Guidelines for detection, management and prevention of hyperbilirubinemia in term and late preterm newborn infants (35 or more weeks' gestation) - summary (2007) J Paediatr Child Health, 12, pp. 401-418
Kaplan, M., Merlob, P., Regev, R., Israel guidelines for the management of neonatal hyperbilirubinemia and prevention of kernicterus (2008) J Perinatol, 28, pp. 389-397
Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation (2004) Pediatrics, 114, pp. 297-316. , American academy of pediatrics. Subcommittee on hyperbilirubinemia
Navarro, M., Negre, S., Matoses, M.L., Necrotizing enterocolitis following the use of intravenous immunoglobulin for haemolytic disease of the newborn (2009) Acta Paediatr, 98, pp. 1214-1217
Viellevoye, R., Rigo, V., Rigo, J., Necrotising enterocolitis after administration of intravenous immunoglobulin in very low birth weigth preterms: A retrospective study (2009) Arch Dis Child, 93, pp. pw587
